Abstract

BackgroundAmeloblasts are epithelially derived cells responsible for enamel formation through a process known as amelogenesis. Amongst the several transcription factors that are expressed during amelogenesis, both Msx2 and Sp6 transcription factors play important role. Msx2 and Sp6 mouse mutants, exhibit similar amelogenesis defects, namely enamel hypoplasia, while humans with amelogenesis imperfecta (AI) carry mutations in the human homologues of MSX2 or SP6 genes. These across species similarities in function indicate that these two transcription factors may reside in the same developmental pathway. In this paper, we test whether they work in a coordinated manner to exert their effect during amelogenesis.MethodsTwo different dental epithelial cell lines, the mouse LS8 and the rat G5 were used for either overexpression or silencing of Msx2 or Sp6 or both. Msx2 mutant mouse embryos or pups were used for in vivo studies. In situ hybridization, semi-quantitative and quantitative real time PCR were employed to study gene expression pattern. MatInspector was used to identify several potential putative Msx2 binding sites upstream of the murine Sp6 promoter region. Chromatin Immunoprecipitation (chIP) was used to confirm the binding of Msx2 to Sp6 promoter at the putative sites.ResultsUsing the above methods we identified that (i) Msx2 and Sp6 exhibit overlapping expression in secretory ameloblasts, (ii) Sp6 expression is reduced in the Msx2 mouse mutant secretoty ameloblasts, and (iii) that Msx2, like Sp6 inhibits follistatin expression. Specifically, our loss-of function studies by silencing Msx2 and/or Sp6 in mouse dental epithelial (LS8) cells showed significant downregulation of Sp6 but upregulation of Fst expression. Transient transfection of Msx2 overexpression plasmid, up-regulated Sp6 and downregulated Fst expression. Additionally, using MatInspector, we identified several potential putative Msx2 binding sites, 3.5 kb upstream of the murine Sp6 promoter region. By chIP, we confirmed the binding of Msx2 to Sp6 promoter at these sites, thus suggesting that Sp6 is a direct target of Msx2.ConclusionCollectively, these results show that Sp6 and Msx2 work in a concerted manner to form part of a network of transcription factors that operate during later stages of tooth development controlling ameloblast life cycle and amelogenesis.

Highlights

  • The development of teeth depends on cell interactions between epithelium and mesenchyme that leads to the differentiation of cells derived from mesenchyme into odontoblasts and of cells derived from epithelium into ameloblasts (Kollar and Lumsden, 1979; Thesleff and Nieminen, 2005)

  • We study the interplay between Msx2, Sp6, and Fst and we show that (i) Sp6 expression is reduced in the Msx2 mouse mutant secretoty ameloblasts, (ii) Msx2, like Sp6 inhibits follistatin expression in vitro, (iii) Sp6 and follistatin are early response genes whose expression is under the control of Msx2, and that (iv) Msx2 binds to Sp6 promoter in vitro, suggesting that Sp6 is a direct target of Msx2

  • The LS8 and G5 “cells express many of the genes specific for amelogenesis, such as ameloblastin, amelogenin, and enamelin, at sufficiently high levels, they have been used for many in vitro studies of amelogenesis, including gene promoter analysis and LS8 cells, in particular, produce an enamel extracellular matrix that is similar to authentic enamel after treatment with peptide amphiphiles” (Zhou et al, 2000; Huang et al, 2008)

Read more

Summary

Introduction

The development of teeth depends on cell interactions between epithelium and mesenchyme that leads to the differentiation of cells derived from mesenchyme into odontoblasts and of cells derived from epithelium into ameloblasts (Kollar and Lumsden, 1979; Thesleff and Nieminen, 2005). Studies in animal models and humans have shown that Msx and Sp6 transcription factors play important role during amelogenesis. In a case of syndromic amelogenesis imperfecta (AI) sequence analysis of the human homolog of MSX2 gene identified a missense mutation of T447C, further indicating the important role of Msx during amelogenesis (Suda et al, 2006). Msx and Sp6 mouse mutants, exhibit similar amelogenesis defects, namely enamel hypoplasia, while humans with amelogenesis imperfecta (AI) carry mutations in the human homologues of MSX2 or SP6 genes. These across species similarities in function indicate that these two transcription factors may reside in the same developmental pathway. We test whether they work in a coordinated manner to exert their effect during amelogenesis

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call